Molecular hydrogen attenuates methamphetamine-induced behavioral sensitization and activation of ERK-ΔFosB signaling in the mouse nucleus accumbens.
Di Wen, Rongji Hui, Yi Liu, Yixiao Luo, Jian Wang, Xi Shen, Bing Xie, Feng Yu, Bin Cong, Chunling Ma · Progress in neuro-psychopharmacology & biological psychiatry · 2020
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In male C57BL/6 mice, due to the anti-oxidative function of molecular hydrogen, the hydrogen-rich saline injections reduced METH-induced reactive oxygen species and malondialdehyde generation in the NAc. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in male C57BL/6 mice. Due to the anti-oxidative function of molecular hydrogen, the hydrogen-rich saline injections reduced METH-induced reactive oxygen species and malondialdehyde generation in the NAc.
What the Researchers Studied
The researchers studied male C57BL/6 mice. The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
Reported treatment duration: 7 days. Due to the anti-oxidative function of molecular hydrogen, the hydrogen-rich saline injections reduced METH-induced reactive oxygen species and malondialdehyde generation in the NAc. The authors concluded that these results suggest that molecular hydrogen serves as an anti-oxidative agent with potentially therapeutic applicability to the treatment of METH addicts.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was male C57BL/6 mice. The study used a preclinical animal experiment. The reported treatment duration was 7 days.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.